Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes.
Saved in:
| Title: | Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. |
|---|---|
| Authors: | McAuliffe PF; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Evans KW; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Akcakanat A; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Chen K; Department of Bioinformatics and Computational Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Zheng X; Department of Bioinformatics and Computational Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Zhao H; Department of Bioinformatics and Computational Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Eterovic AK; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Sangai T; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Holder AM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Sharma C; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Chen H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Tarco E; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Gagea M; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Naff KA; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Sahin A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Multani AS; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Black DM; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Mittendorf EA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Bedrosian I; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Mills GB; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Gonzalez-Angulo AM; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Meric-Bernstam F; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. |
| Source: | PloS one [PLoS One] 2015 Sep 01; Vol. 10 (9), pp. e0136851. Date of Electronic Publication: 2015 Sep 01 (Print Publication: 2015). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26325287 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22McAuliffe+PF%22">McAuliffe PF</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Evans+KW%22">Evans KW</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Akcakanat+A%22">Akcakanat A</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Chen+K%22">Chen K</searchLink>; Department of Bioinformatics and Computational Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Zheng+X%22">Zheng X</searchLink>; Department of Bioinformatics and Computational Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Zhao+H%22">Zhao H</searchLink>; Department of Bioinformatics and Computational Science, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Eterovic+AK%22">Eterovic AK</searchLink>; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Sangai+T%22">Sangai T</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Holder+AM%22">Holder AM</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Sharma+C%22">Sharma C</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Chen+H%22">Chen H</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Do+KA%22">Do KA</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Tarco+E%22">Tarco E</searchLink>; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Gagea+M%22">Gagea M</searchLink>; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Naff+KA%22">Naff KA</searchLink>; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Sahin+A%22">Sahin A</searchLink>; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Multani+AS%22">Multani AS</searchLink>; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Black+DM%22">Black DM</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Mittendorf+EA%22">Mittendorf EA</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Bedrosian+I%22">Bedrosian I</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Mills+GB%22">Mills GB</searchLink>; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Angulo+AM%22">Gonzalez-Angulo AM</searchLink>; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.<br /><searchLink fieldCode="AU" term="%22Meric-Bernstam+F%22">Meric-Bernstam F</searchLink>; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101285081%22">PloS one</searchLink> [PLoS One] 2015 Sep 01; Vol. 10 (9), pp. e0136851. <i>Date of Electronic Publication: </i>2015 Sep 01 (<i>Print Publication: </i>2015). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101285081 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-6203 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219326203%22">19326203 </searchLink><i>NLM ISO Abbreviation: </i>PLoS One <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26325287 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pone.0136851 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0136851 Titles: – TitleFull: Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: McAuliffe PF – PersonEntity: Name: NameFull: Evans KW – PersonEntity: Name: NameFull: Akcakanat A – PersonEntity: Name: NameFull: Chen K – PersonEntity: Name: NameFull: Zheng X – PersonEntity: Name: NameFull: Zhao H – PersonEntity: Name: NameFull: Eterovic AK – PersonEntity: Name: NameFull: Sangai T – PersonEntity: Name: NameFull: Holder AM – PersonEntity: Name: NameFull: Sharma C – PersonEntity: Name: NameFull: Chen H – PersonEntity: Name: NameFull: Do KA – PersonEntity: Name: NameFull: Tarco E – PersonEntity: Name: NameFull: Gagea M – PersonEntity: Name: NameFull: Naff KA – PersonEntity: Name: NameFull: Sahin A – PersonEntity: Name: NameFull: Multani AS – PersonEntity: Name: NameFull: Black DM – PersonEntity: Name: NameFull: Mittendorf EA – PersonEntity: Name: NameFull: Bedrosian I – PersonEntity: Name: NameFull: Mills GB – PersonEntity: Name: NameFull: Gonzalez-Angulo AM – PersonEntity: Name: NameFull: Meric-Bernstam F IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2015 Sep 01 Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1932-6203 Numbering: – Type: volume Value: 10 – Type: issue Value: 9 Titles: – TitleFull: PloS one Type: main |
| ResultId | 1 |